Search results
-
ASCO 2025 – Exelixis’s son of Cabometyx improves
ASCO 2025 – Exelixis’s son of Cabometyx improves …
- 06/05/2025 - 11:12 -
ASCO 2025 – zilo-V adds a patient death to its tox tally
ASCO 2025 – zilo-V adds a patient death to its tox tally …
- 06/01/2025 - 21:07 -
ASCO 2025 – Astra's Matterhorn could break new ground
ASCO 2025 – Astra's Matterhorn could break new ground …
- 06/01/2025 - 21:22 -
ASCO 2025 – Astra seeks a new SERD paradigm
ASCO 2025 – Astra seeks a new SERD paradigm …
- 06/02/2025 - 14:04 -
ASCO 2025 – Enhertu mounts its first-line charge
ASCO 2025 – Enhertu mounts its first-line charge … HR=0.56; p<0.00001 HR=0.62, p<0.0001 Source: ASCO 2025, Perjeta label. Discussing the results at …
- 06/04/2025 - 14:52 -
ASCO 2025 – Trodelvy heads for the front line
ASCO 2025 – Trodelvy heads for the front line … 31% TEAE-related death 3% 3% Source: ASCO 2025. Ascent-04 also saw an “early trend” …
- 06/01/2025 - 21:07 -
ASCO 2025 – vepdegestrant matches rival degraders
ASCO 2025 – vepdegestrant matches rival degraders …
- 06/01/2025 - 21:07 -
ASCO 2025 – Braftovi breaks new ground
ASCO 2025 – Braftovi breaks new ground …
- 05/31/2025 - 14:02 -
ASCO 2025 preview – KRAS challengers assemble
ASCO 2025 preview – KRAS challengers assemble … when their titles were revealed . Selected ASCO 2025 regular presentations for small molecules …
- 05/28/2025 - 10:07 -
ASCO 2025 preview – Kura looks similar to Syndax
ASCO 2025 preview – Kura looks similar to Syndax … differentiation syndrome 13% 13% Source ASCO 2025 abstract Nov 2024 PR Regulatory status …
- 05/28/2025 - 16:41
